Efficacy of Bromocriptine Versus Breast Binders as Inhibitors Of Postpartum Lactation

Arthur G. Shapiro, Linda Thomas

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Fifty postpartum patients were randomly given either bromocriptine (2.5 mg by mouth b.i.d. x 30 doses) or breast binders for inhibiting lactation. The breast binder group had a high incidence of symptoms (breast pain, engorgement, secretion) for the first week postpartum; these symptoms rapidly decreased by the second week. Bromocriptine successfully suppressed the breast problems in virtually all of the patients who took the drug correctly. Because of the high rate of side effects and a significant incidence of 'rebound', the dosage of bromocriptine should probably be changed, and we recommend a revised dosage.

Original languageEnglish (US)
Pages (from-to)719-721
Number of pages3
JournalSouthern medical journal
Volume77
Issue number6
DOIs
StatePublished - Jun 1984

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Efficacy of Bromocriptine Versus Breast Binders as Inhibitors Of Postpartum Lactation'. Together they form a unique fingerprint.

  • Cite this